Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Norovirus Treatment Market Size And Revenue Outlook Through 2030
The norovirus treatment market has experienced swift expansion recently. It is projected to expand from $1.94 billion in 2025 to $2.15 billion in 2026, at a compound annual growth rate (CAGR) of 10.9%. The expansion observed in the historic period is attributable to limited awareness of norovirus management, a reliance on hospital-based treatments, insufficient homecare infrastructure, the absence of standardized symptom management protocols, and low adoption of probiotics and zinc supplementation.
The norovirus treatment market size is expected to experience significant expansion in the coming years, projected to reach $3.22 billion in 2030, growing at a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period can be attributed to factors such as increasing demand for oral rehydration solutions, the expansion of homecare services and telemedicine, a heightened focus on pediatric and elderly populations, the development of targeted supportive care therapies, rising healthcare expenditure, and awareness campaigns. Major trends anticipated during this period include the increasing adoption of oral rehydration therapies, a rise in the use of intravenous fluids for severe cases, the growth of homecare and remote treatment options, an expanded use of anti-diarrheal and symptom management drugs, and a specific focus on pediatric and geriatric norovirus care.
Get A Free Sample Report With In-Depth Market Insights:
Norovirus Treatment Market Industry Drivers: What’s Behind The Revenue Growth?
The growing incidence of infectious diseases is anticipated to drive the expansion of the norovirus treatment market. Such diseases are ailments resulting from bacteria, viruses, fungi, or parasites that can spread among individuals, encompassing conditions like influenza, tuberculosis, HIV/AIDS, malaria, and norovirus. The rise in infectious diseases stems from urban population density, which aids in the quicker spread of pathogens within crowded communities. Norovirus treatment plays a role in mitigating the effects of infectious diseases by effectively addressing symptoms and curbing dissemination through appropriate hydration, hygiene, and isolation techniques. For instance, in March 2025, the World Health Organization, a Switzerland-based intergovernmental organization, reported that approximately 10.8 million individuals, including 6.0 million men, 3.6 million women, and 1.3 million children, were affected by tuberculosis worldwide in 2023. Consequently, the heightened occurrence of infectious disease is stimulating the growth of the norovirus treatment market.
Norovirus Treatment Market Segment Outlook: Which Categories Are Growing Fastest?
The norovirus treatment market covered in this report is segmented –
1) By Treatment: Electrolytes, Intravenous Fluids, Antipyretics, Analgesics, Anti-Diarrheal, Other Treatments
2) By Diagnosis: Bacteria Culture Test, Stool Tests, Other Diagnosis
3) By Route Of Administration: Oral, Intravenous
4) By End User: Hospitals, Clinics, Homecare Settings
Subsegments:
1) By Electrolytes: Oral Rehydration Salts (ORS), Sports Drinks, Pediatric Electrolyte Solutions
2) By Intravenous Fluids: Crystalloids, Colloids, Lactated Ringer’s Solution
3) By Antipyretics: Acetaminophen (Paracetamol), Ibuprofen, Aspirin
4) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen-Based Analgesics
5) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Diphenoxylate-Atropine
6) By Other Treatments: Antiemetics, Probiotics, Zinc Supplements
#Norovirus Treatment Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies active in the norovirus treatment market are concentrating on developing innovative solutions, such as advanced mRNA vaccines, with the goal of accelerating the creation of targeted immunization, boosting protection against severe infections, and reducing the global impact of norovirus-related illnesses. Advanced mRNA vaccines are a new generation of immunizations that employ specially engineered messenger RNA to instruct cells to synthesize specific proteins, thereby triggering a focused immune response with enhanced stability, effectiveness, and adaptability against various infectious diseases. For example, in October 2024, Moderna Inc., a US-based biotechnology company, collaborated with the UK Health Security Agency (UKHSA), a UK-based government agency, to commence the world’s first Phase 3 trial of an mRNA norovirus vaccine (mRNA-1403) in the UK. This trial introduces a vaccine intended to combat the highly contagious norovirus by instructing the body to produce viral proteins that stimulate a strong immune response, without utilizing the live virus. Noteworthy aspects of the launch include its application of stabilized mRNA for improved durability, its potential for rapid development in response to evolving strains, and its capacity to induce both antibody and T-cell responses.
Norovirus Treatment Market Leading Companies And Competitive Benchmarking
Major companies operating in the norovirus treatment market are Abbott Laboratories, Reckitt Benckiser Group plc, Nestlé Health Science, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, Mylan (Viatris Inc.), Perrigo Company plc, Haleon plc, Church & Dwight Co. Inc., GlaxoSmithKline Consumer Healthcare, Sanofi Consumer Healthcare, Pfizer Consumer Healthcare, Ferring Pharmaceuticals, Fresenius Kabi AG, Baxter International Inc., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Pfizer Healthcare India Pvt. Ltd., Mead Johnson Nutrition (Reckitt), Danone Nutricia, Amneal Pharmaceuticals Inc., Ajanta Pharma Ltd.
View The Full Norovirus Treatment Market Report:
Norovirus Treatment Market Geographic Spread And Regional Opportunities
North America was the largest region in the norovirus treatment market in 2025. The regions covered in the norovirus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model